cannabis indica

Índice completo — página 3 de 77

Estudos 201 a 300 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2023. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 201 a 300

  1. 2023

    Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease

  2. 2023

    Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status

    FavorávelEstudo LaboratorialCâncerCâncer — Próstata
  3. 2023

    Anticancer effect of terpenes: focus on malignant melanoma

    FavorávelMetanáliseCâncerCâncer — Melanoma
  4. 2023

    Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence

  5. 2023

    Assessment of Medical Cannabis and Health-Related Quality of Life

    FavorávelMetanáliseDorDor — Crônica
  6. 2023

    Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)
  7. 2023

    Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents

  8. 2023

    Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty Acids

    FavorávelEnsaio ClínicoDorDor — CrônicaEnxaquecaDietaÔmega-3+2
  9. 2023

    Associations of Momentary Mindfulness With Affect and Cannabis Desire in a Trial of Cannabis Use Interventions With and Without Momentary Assessment

  10. 2023

    Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults

  11. 2023

    Associations of the P300 Event-Related Potentials and Self-Reported Craving in Substance Use Disorders: A Systematic Review

  12. 2023

    Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review

  13. 2023

    Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis

    FavorávelMetanálise ClínicaInflamaçãoPsicoseAnandamida (AEA)
  14. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+26
  15. 2023

    Bridging the gap between genetic epidemiological research and prevention: A randomized control trial of a novel personalized feedback program for alcohol and cannabis use

  16. 2023

    Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides+4
  17. 2023

    Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial

    DesfavorávelEnsaio ClínicoDisfunção Cognitiva
  18. 2023

    Canine immune cells express high levels of CB1 and CB2 cannabinoid receptors and cannabinoid-mediated alteration of canine cytokine production is vehicle-dependent

    FavorávelEstudo LaboratorialAplicações Veterinárias
  19. 2023

    CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study

    FavorávelEnsaio Clínico Duplo-CegoDepressãoTDA e TDAHTiques e Síndrome de TouretteTHC:CBD Farmacêutico+1
  20. 2023

    Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis

    FavorávelEstudo LaboratorialDoença de AlzheimerTetraidrocanabinol (THC)Canabicromeno (CBC)+1
  21. 2023

    Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report

    FavorávelMetanáliseDorInflamaçãoAnsiedade+4
  22. 2023

    Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

    DesfavorávelMetanálise ClínicaDor — CrônicaDor — AgudaDor — Neuropatia Periférica+7
  23. 2023

    Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines.

    FavorávelEstudo LaboratorialInflamaçãoVitamina D
  24. 2023

    Cannabidiol (CBD) with 4',7-Isoflavandiol (Equol) Efficacy is Greater than CBD or Equol Treatment Alone via Human Skin Gene Expression Analysis

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoDoenças de PeleCanabigerol (CBG)+3
  25. 2023

    Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2

    FavorávelEstudo LaboratorialDependência QuímicaInflamaçãoDependência — Opioides
  26. 2023

    Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+7
  27. 2023

    Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerDor — CrônicaTHC FarmacêuticoTHC:CBD Farmacêutico+9
  28. 2023

    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDepressão
  29. 2023

    Cannabidiol as an Alternative Analgesic for Acute Dental Pain

    FavorávelEnsaio Clínico Duplo-CegoDorDor — AgudaDoença PeriodontalCBD Farmacêutico+2
  30. 2023

    Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  31. 2023

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

    FavorávelMetanáliseDisfunção CognitivaPsicoseEsquizofreniaAnandamida (AEA)+1
  32. 2023

    Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder

    FavorávelEstudo em AnimaisAnsiedadeDepressãoDisfunção CognitivaCanabicromeno (CBC)+5
  33. 2023

    Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use

  34. 2023

    Cannabidiol sensitizes TRPV2 channels to activation by 2-APB

    FavorávelEstudo em AnimaisEstresse OxidativoCapsaicina (CAPS)
  35. 2023

    Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene-related peptide's brain levels

    FavorávelEstudo em AnimaisDependência QuímicaAnsiedadeDependência — Álcool+1
  36. 2023

    Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome

    FavorávelEnsaio ClínicoAnsiedadeSíndrome de Sturge-WeberCBD Farmacêutico
  37. 2023

    Cannabidiol-enriched cannabis extraction product in Parkinson's disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoDoença de ParkinsonCBD Farmacêutico+2
  38. 2023

    Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — Cérebro+3
  39. 2023

    Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy

    FavorávelEstudo LaboratorialCâncerInflamaçãoEstresse OxidativoTHC Farmacêutico+13
  40. 2023

    Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoDoenças de Pele+4
  41. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  42. 2023

    Cannabidiol's impact on drug-metabolization

    InconclusivoEstudo LaboratorialEfeitos Adversos da Cannabis
  43. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

  44. 2023

    Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

    FavorávelEstudo em AnimaisDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  45. 2023

    Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3

  46. 2023

    Cannabinoids for symptom management in children with cancer: It's complicated

    InconclusivoMetanáliseDorCâncerDor — Oncológica+1
  47. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+16
  48. 2023

    Cannabis and Psychosis.

    DesfavorávelMetanálisePsicose
  49. 2023

    Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis

    FavorávelMetanálisePouchite
  50. 2023

    Cannabis use amongst tinnitus patients: consumption patterns and attitudes

    FavorávelMetanáliseZumbido
  51. 2023

    Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns

    FavorávelEnsaio ClínicoDorDepressãoInsônia e Distúrbios do Sono
  52. 2023

    Cannabis use disorders and outcome of admission to intensive care: A retrospective multi-centre cohort study

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — Cannabis
  53. 2023

    Cannabis use does not increase actual creativity but biases evaluations of creativity

    InconclusivoEnsaio ClínicoDisfunção Cognitiva
  54. 2023

    Cannabis use for exercise recovery in trained individuals: a survey study

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisExercício Físico+2
  55. 2023

    Cannabis use for medical symptoms: Patterns over the first year of use

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+3
  56. 2023

    Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review

    InconclusivoMetanálisePsicoseTDA e TDAH
  57. 2023

    Cannabis use in sub-Saharan Africa: A systematic review and meta-analysis

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  58. 2023

    Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose MúltiplaCanabinoide Sintético (não especificado)+3
  59. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  60. 2023

    Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+8
  61. 2023

    Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

  62. 2023

    CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

  63. 2023

    CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects

    FavorávelEstudo em AnimaisDepressão
  64. 2023

    CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial

  65. 2023

    CBD-oil as a potential solution in case of severe tamoxifen-related side effects

    FavorávelEnsaio ClínicoDorCâncerInsônia e Distúrbios do Sono+3
  66. 2023

    CBD: A Potential Lead against Hair Loss, Alopecia, and its Potential Mechanisms

    FavorávelMetanáliseQueda de Cabelo
  67. 2023

    Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

  68. 2023

    Chitosan Sponges for Efficient Accumulation and Controlled Release of C-Phycocyanin

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoInfecções BacterianasFicocianina+2
  69. 2023

    Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover Study

  70. 2023

    Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients

    FavorávelMetanáliseHemodiáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  71. 2023

    Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain

    FavorávelMetanáliseDorDor — CrônicaTetraidrocanabinol (THC)THC Farmacêutico+2
  72. 2023

    Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis

  73. 2023

    Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — Aguda+3
  74. 2023

    Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients

    FavorávelMetanálise ClínicaDorDor — OncológicaTHC:CBD Farmacêutico
  75. 2023

    Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  76. 2023

    Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome

  77. 2023

    Co-use of cigarettes and cannabis among people with HIV: Results from a randomized controlled smoking cessation trial

  78. 2023

    Cocaine-Induced Raynaud's Phenomenon: A Case Report

  79. 2023

    Cognitive behavioral therapy for insomnia to reduce cannabis use: Results from a pilot randomized controlled trial

  80. 2023

    Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaDoenças NeurodegenerativasDoença de Parkinson
  81. 2023

    Combining cannabis and melatonin treatment with a rehabilitation program improved symptoms in a dog with compulsive disorder: A case report

    FavorávelEnsaio Clínico VeterinárioAplicações VeterináriasCanabigerol (CBG)
  82. 2023

    COMPARING DEHULLED HEMP MEAL AND CANOLA MEAL AS A PROTEIN SUPPLEMENT FOR LACTATING DAIRY COWS

  83. 2023

    Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

    FavorávelMetanáliseDorAnsiedadeDor — Crônica
  84. 2023

    Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial

  85. 2023

    Comparison of the influence of alcohol and cannabis on the dynamics of the accommodative response

  86. 2023

    Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS-MS analysis in urine

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Delta-8-THC
  87. 2023

    Could cannabinoids provide a new hope for ovarian cancer patients?

  88. 2023

    County-level predictors of US drug overdose mortality: A systematic review

    InconclusivoMetanáliseDependência QuímicaDependência — Opioides
  89. 2023

    Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach

  90. 2023

    Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Pâncreas
  91. 2023

    Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol

    FavorávelEstudo LaboratorialEstresse OxidativoCanabinoides Sintéticos WIN-x
  92. 2023

    Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

  93. 2023

    Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisDependência — CannabisAnsiedade
  94. 2023

    Delta-8-THC association with psychosis: A case report with literature review

  95. 2023

    Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study

    FavorávelEnsaio ClínicoDorDependência QuímicaDisfunção CognitivaTHC Farmacêutico+1
  96. 2023

    Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership

    DesfavorávelEnsaio ClínicoDorDependência QuímicaEfeitos Adversos da Cannabis+4
  97. 2023

    Digital screening and brief intervention for illicit drug misuse in college students: A mixed methods, pilot, cluster, randomized trial from India

  98. 2023

    Disclosing Environmental Ligands of L-FABP and PPARγ: Should We Re-evaluate the Chemical Safety of Hydrocarbon Surfactants?

    InconclusivoEstudo LaboratorialProteína Ligadora de Ácidos Graxos (FABP)
  99. 2023

    Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists

    FavorávelEstudo LaboratorialTetraidrocanabinol (THC)
  100. 2023

    Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisPsicose+5